ED from prostate cancer hormone therapy treatable (Reuters)

Reuters - A new study shows that a
substantial minority of men receiving so-called androgen
deprivation therapy, or ADT, for prostate cancer experience
erectile dysfunction (ED). However, many respond well to ED
therapy, doctors from Memphis have found.

View Original Article